Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Lipocine (LPCN) over the last 8 years, with Q3 2025 value amounting to 0.25.

  • Lipocine's Asset Utilization Ratio fell 2716.86% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 2716.86%. This contributed to the annual value of 0.49 for FY2024, which is 42254.75% up from last year.
  • Lipocine's Asset Utilization Ratio amounted to 0.25 in Q3 2025, which was down 2716.86% from 0.22 recorded in Q2 2025.
  • Over the past 5 years, Lipocine's Asset Utilization Ratio peaked at 0.52 during Q4 2024, and registered a low of 0.0 during Q1 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.22 (2025), whereas its average is 0.21.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 36530.75% in 2021, then soared by 12745358.5% in 2022.
  • Quarter analysis of 5 years shows Lipocine's Asset Utilization Ratio stood at 0.35 in 2021, then tumbled by 96.25% to 0.01 in 2022, then skyrocketed by 854.42% to 0.12 in 2023, then soared by 317.99% to 0.52 in 2024, then tumbled by 51.86% to 0.25 in 2025.
  • Its Asset Utilization Ratio stands at 0.25 for Q3 2025, versus 0.22 for Q2 2025 and 0.17 for Q1 2025.